miscsubjectsAI governance
Evidence review

PT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathways

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-chemo`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-chemo

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-chemo/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-chemo/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-chemo/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-chemo/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why PT-141 might help you

  1. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

Why Gabapentin / pregabalin matters for you

  1. Drug: Gabapentin / pregabalin
  2. What it does: Masks neuropathic pain signal; does not repair nerve.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • PT-141 → sexual / CNS arousal

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Quantified confidence (this ledger): 0.45 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials (source s0)

Phase 3 trial results in HSDD population.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Bremelanotide - an overview (source s17)

Explicit statement on lack of cancer data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

A Comparison of Pregabalin and Gabapentin in Palliative Care (source s26)

Details the single comparative trial in cancer pain.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Beginner's Guide: Using PT-141 — Reddit, r/PeptideGuide (source s29)

Example anecdotal mention touching on chemo context.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

chemo · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 5 sources · swipe →chain 70bdf941e6d7 · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
human
Two phase 3 randomized trials showed bremelanotide improved desire scores versus placebo in premenopausal women with HSDD.
sources: s0
humanlow confidence
No published randomized trials study bremelanotide in cancer survivors or chemotherapy patients.
sources: s17
humanlow confidence
One randomized trial found pregabalin superior to gabapentin for cancer-related neuropathic pain on VAS scores and opioid use.
sources: s26
mechanisticlow confidence
PT-141 acts via melanocortin receptor agonism in central pathways linked to sexual motivation.
sources: s2
anecdotallow confidence
Reddit and X mentions of PT-141 with chemotherapy are sparse personal accounts without controlled verification.
sources: s29
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:20
PT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathways · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Chemo
Slug: pt-141-chemo
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"pt-141","name":"PT-141"}],"drugs_in_scope":["gabapentin-lyrica"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"deg
it output
{
  "slug": "pt-141-chemo",
  "title": "PT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathways",
  "body": "## What's breaking down\n\nChemotherapy often disrupts multiple body systems at once. Nerve endings in the periphery can suffer direct toxicity, producing neuropathic pain or numbness. Hormonal shifts and fatigue commonly reduce overall energy and drive. Sexual function layers are frequently hit: desire and arousal signals from the central nervous system can weaken even when physical sensation remains intact. These changes are not uniform; some patients report preserved physical response but lowered motivation, while others experience combined pain and motivational loss. The net result is that repair pathways for tissue and neural signaling fall behind the ongoing stress of treatment.\n\nNo single peptide or drug reverses the full picture. The sections below examine two compounds discussed in this context, PT-141 and gabapentin/pregabalin, through the lens of what each is studied to do at specific layers.\n\n## Why PT-141 might help you\n\nPT-141 (bremelanotide) is studied for its action on melanocortin receptors in the brain. These receptors sit in pathways that influence sexual motivation and arousal.\n\nIf your chemotherapy experience includes reduced sexual desire or difficulty with arousal despite preserved sensation, the logic chain runs like this
0eda6e171add3ddb
Machine verification: /api/articles/pt-141-chemo/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Two phase 3 randomized trials showed bremelanotide improved desire scores versus placebo in premenopausal women with HSDD."?
ask pt-141-chemo claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "No published randomized trials study bremelanotide in cancer survivors or chemotherapy patients."?
ask pt-141-chemo claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "One randomized trial found pregabalin superior to gabapentin for cancer-related neuropathic pain on VAS scores and opioid use."?
ask pt-141-chemo claim c4 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "PT-141 acts via melanocortin receptor agonism in central pathways linked to sexual motivation."?
ask pt-141-chemo claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit and X mentions of PT-141 with chemotherapy are sparse personal accounts without controlled verification."?
ask pt-141-chemo claim c5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Example anecdotal mention touching on chemo context."
ask pt-141-chemo source s29 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathways — and what would you need me to tell you first?
ask pt-141-chemo condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathways (studies vs anecdotes)?
ask pt-141-chemo good bad experiences · paste includes §SELF
pt-141-chemo · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 18223 tokens · $0 · 2 models
chain head 618c2649e9df4905
write grok/grok-4.3 · 2026-06-30 01:20 · 18223 tok · 539ba65fd454
voxel_divide owner · 2026-07-17 02:41 · 0 tok · 618c2649e9df
verify chain →
Live ledger · 6 payloads · 2 turns
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-20 00:02
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 21:19
PROTOCOL_RUN dispatch · 2026-06-30 01:20 · t_gdr2f9ti
PROTOCOL_RUN dispatch · 2026-06-30 01:20 · t_q87mq27g
PROTOCOL_RUN dispatch · 2026-06-30 01:20 · t_gdr2f9ti
PROTOCOL_RUN dispatch · 2026-06-30 01:20 · t_q87mq27g
view full ledger & cards →
REST + ledger
read GET /api/articles/pt-141-chemo · GET /api/articles/pt-141-chemo?format=post (the editable body)
create/replace POST /api/articles/pt-141-chemo · PUT /api/articles/pt-141-chemo (replace, keeps revision) · PATCH /api/articles/pt-141-chemo (merge)
delete DELETE /api/articles/pt-141-chemo
writes need header x-terminal-key
LLM bundle GET /api/articles/pt-141-chemo/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim pt-141-chemo|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…